Press "Enter" to skip to content

Antibody drug that can neutralize all mutations of the corona virus has started human trials: LY-CoV1404 – Health News


On the other hand, to support its ongoing efforts against Covid-19 and other viral threats, AbCellera recently laid the groundwork to expand its headquarters in Vancouver. The project is expected to allow the company to grow significantly over the next few years, adding hundreds of employees to the existing 250-person workforce.

The expansion is aimed to include two facilities with a total area of ​​115,000 square meters, and these facilities are expected to be completed in 2023 and 2024.

“We are building state-of-the-art facilities in Vancouver to accelerate the development of new antibody therapies with biotech and pharmaceutical partners from around the world. This tech campus is a place where talented people can contribute to significantly improving and accelerating antibody discovery for the benefit of patients everywhere,” Hansen said in a statement. We aim to serve as “he said.


Be First to Comment

Leave a Reply

Your email address will not be published. Required fields are marked *